NVO and MTSR Related Headlines
Go Back- Novo Nordisk shares rise on investor relief after it exits Metsera bid
- Novo CEO Says Bid For Metsera Is Higher Than Pfizer's Is Today
- Novo Nordisk Is Said To Sweeten Bid For Obesity Startup Metsera - Bloomberg
- Pfizer, Novo again raise Metsera bids in intensifying obesity drug battle
- Pfizer vows to continue Metsera legal fight after court denies restraining order
- Pfizer Preps Improved Offer In Metsera Bidding War - WSJ
- Pfizer Denied Temporary Block On Novo Nordisk’s Metsera Bid - Bloomberg
- Pfizer Drops Demand That Metsera Denounce Novo Bid: Metsera - Bloomberg
- FTC Says Novo-Metsera Bid Raises Merger Filing Concerns - Bloomberg
- Pfizer has removed conditions on sale of Arch Venture shares and Metsera public statements from its Metsera bid - Pfizer letter to court
- Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo
- Pfizer (PFE) CEO: our bid for Metsera has taken into consideration that prices of GLP-1 will probably start going down - Conference Call
- Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
- Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies - FT
- Metsera declares Novo Nordisk's $10 billion bid superior to Pfizer offer
- Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior"
- Novo Nordisk says Metsera bid won't raise antitrust issues
- Metsera responds to Pfizer litigation amid competing acquisition bids
- Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit
- Pfizer files second lawsuit against Novo Nordisk over Metsera acquisition
- Metsera responds to Pfizer litigation, will address claims in court
- Pfizer sues Metsera directors and Novo Nordisk over merger breach
- Pfizer gets early FTC clearance for Metsera acquisition
- Pfizer mulls suing Metsera, Novo Nordisk over topping bid - Semafor
- Metsera Was Previously in Exclusive Talks with Bristol-Myers Squibb, Sources Say -- WSJ
- Novo Nodrisk stock dips on aggressive odder to buy Metsera, 'reckless' says Pfizer
- Novo Nordisk makes $9 billion bid for Metsera amid Pfizer deal
- Metsera Receives Unsolicited Proposal from Novo Nordisk
- Pfizer calls Novo Nordisk's Metsera bid reckless and illegal
- Pfizer Addresses Proposal for Metsera
- Novo Nordisk submits $6.5 billion offer for Metsera
- Chardan Comments on iBio, Inc. (IBIO)
NVO and MTSR Related Press Releases
Go Back- Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior"
- Metsera Receives Unsolicited Proposal from Novo Nordisk
- Pfizer Addresses Proposal for Metsera
